pluristem therapeutics inc
(PSTI:Consolidated Issue listed on NASDAQ Capital Market)
Frank C. Carlucci
Head of Strategic Business Advisory Board, Pluristem Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 110 board members in 14 different organizations across 21 different industries.|
See Board Relationships
Mr. Frank C. Carlucci is a Senior Advisor and Member of Advisory Board of Monument Capital Group, LLC. He is a Co-Founder of Frontier Group. Mr. Carlucci serves as Counselor of Center for Strategic and International Studies, Inc. He served as a Managing Director of The Carlyle Group since 1989. Since 1993, Mr. Carlucci served as the Partner of The Carlyle Group and also served as its Vice Chairman from 1989 to 1993. He served as the Chief Executive Officer and Chairman ...
MATAM Advanced Technology ParkPhone: 972 7 4710 8759
Haifa, -- 31905
Fax: 972 7 4710 8765
Board Members Memberships*
Former Chairman of the Board
Former Director and Member of Compensation & Corporate Governance Committee
Director and Member of Nominating and Corporate Governance Committee
Vice Chairman, Member of Compensation Committee, Member of Audit Committee and Member of Executive Committee
Vice Chairman, Member of Nomination & Corporate Governance Committee and Member of Compensation Committee
Harvard Business School
Honorary Doctorate 1989
University of Scranton
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Dominick C. Colangelo Esq.||Chief Executive Officer, President, Treasurer and Director|
Aastrom Biosciences, Inc.
|William M. Greenman||Chief Executive Officer, President and Director|
|Gary R. Maharaj||Chief Executive Officer, President and Director|
|Eamonn P. Hobbs||Chief Executive Officer, President, Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee|
Antares Pharma Inc.
|Bernard A. Hausen M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Chief Medical Officer, Director and Member of Strategic Review Committee|
|$381.3K||Compensation as of Fiscal Year 2013.|